The Fate of DCIS After Neoadjuvant Treatment for Invasive Breast Cancer

被引:0
|
作者
Porter, Catherine [1 ]
Morrison, Douglas [1 ]
Wapnir, Irene [1 ]
机构
[1] Stanford Hosp, Stanford, CA USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:94 / 95
页数:2
相关论文
共 50 条
  • [31] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer - A phase II study
    Sarid, David
    Ron, Ilan G.
    Sperber, Fani
    Stadler, Yona
    Kahan, Perry
    Kovner, Felix
    Ben-Yosef, Rami
    Marmor, Sylvia
    Grinberg, Yulia
    Maimon, Natalie
    Weinstein, Juliana
    Yaal-Hahoshen, Neora
    [J]. CLINICAL DRUG INVESTIGATION, 2006, 26 (12) : 691 - 701
  • [32] Breast-conserving treatment after neoadjuvant chemotherapy in large breast cancer
    Inaji H.
    Komoike Y.
    Motomura K.
    Kasugai T.
    Sawai Y.
    Koizumi M.
    Nose T.
    Koyama H.
    [J]. Breast Cancer, 2002, 9 (1) : 20 - 25
  • [33] Neoadjuvant treatment with paclitaxel and epirubicin in invasive breast cancer: a phase II study
    Ron, IG
    Sarid, DL
    Wigler, N
    Inbar, MJ
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, : 199 - 199
  • [34] Resolution of DCIS in patients with early breast cancer receiving primary chemotherapy for invasive breast cancer
    Chowdhury, M. H. R.
    Thillai, K.
    Lucey, A.
    Michalarea, V.
    Mera, A.
    Karapanagiotou, E.
    Sandri, I.
    Mansi, J.
    [J]. CANCER RESEARCH, 2017, 77
  • [35] The role of preoperative MRI in negative margins after breast conserving surgery in patients with invasive breast cancer or purely DCIS
    Vos, Elvira L.
    Voogd, Adri C.
    Verhoef, Cornelis
    Obdeijn, Inge-Marie
    Koppert, Linetta B.
    [J]. CANCER RESEARCH, 2015, 75
  • [36] Secondary Breast Cancer after DCIS: Impact of Initial Radiation Therapy on Mortality Associated with Invasive Second Breast Cancers
    Li, P. C.
    Cronin, A. M.
    Punglia, R. S.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E579 - E579
  • [37] DCIS after 11G directional vacuum assisted biopsy: underestimation of invasive breast cancer
    Pizzamiglio, M.
    Fava, V.
    Cassano, E.
    Abbate, F.
    Bozzini, A.
    Renne, G.
    Bellomi, M.
    [J]. EJC SUPPLEMENTS, 2004, 2 (03): : 94 - 94
  • [38] The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective study
    Ploumen, R. A. W.
    Keymeulen, K. B. M., I
    Kooreman, L. F. S.
    van Kuijk, S. M. J.
    Siesling, S.
    Smidt, M. L.
    van Nijnatten, T. J. A.
    [J]. EJSO, 2022, 48 (01): : 60 - 66
  • [39] Subsequent invasive breast cancer risk after DCIS treatment in multinational PRECISION consortium cohorts comprising 48,576 patients
    Schmitz, Renee S.
    van den Belt-Dusebout, Alexandra W.
    Clements, Karen
    Ren, Yi
    Cresta, Chiara
    Timbres, Jasmine
    Liu, Yat-Hee
    Byng, Danalyn
    Lynch, Thomas
    Menegaz, Brian
    Collyar, Deborah
    Hyslop, Terry
    Schaapveld, Michael
    Sawyer, Elinor
    Hwang, Shelley E.
    Thompson, Alastair
    Ryser, Marc D.
    Wesseling, Jelle
    Lips, Esther H.
    Schmidt, Marjanka K.
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [40] Predicting invasive breast cancer versus DCIS in different age groups
    Mehmet US Ayvaci
    Oguzhan Alagoz
    Jagpreet Chhatwal
    Alejandro Munoz del Rio
    Edward A Sickles
    Houssam Nassif
    Karla Kerlikowske
    Elizabeth S Burnside
    [J]. BMC Cancer, 14